Literature DB >> 11949992

Prevention of group B streptococcal infection in newborns: recommendation statement from the Canadian Task Force on Preventive Health Care.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11949992      PMCID: PMC100929     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  21 in total

1.  Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis.

Authors:  S J Schrag; S Zywicki; M M Farley; A L Reingold; L H Harrison; L B Lefkowitz; J L Hadler; R Danila; P R Cieslak; A Schuchat
Journal:  N Engl J Med       Date:  2000-01-06       Impact factor: 91.245

2.  Prevention of neonatal group B streptococcal disease: intrapartum detection and chemoprophylaxis of heavily colonized parturients.

Authors:  N Tuppurainen; M Hallman
Journal:  Obstet Gynecol       Date:  1989-04       Impact factor: 7.661

3.  Antibiotic resistance patterns of group B streptococci in pregnant women.

Authors:  K Berkowitz; J A Regan; E Greenberg
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

4.  Population-based active surveillance for neonatal group B streptococcal infections in Alberta, Canada: implications for vaccine formulation.

Authors:  H D Davies; S Raj; C Adair; J Robinson; A McGeer
Journal:  Pediatr Infect Dis J       Date:  2001-09       Impact factor: 2.129

5.  Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis.

Authors:  K M Boyer; S P Gotoff
Journal:  N Engl J Med       Date:  1986-06-26       Impact factor: 91.245

6.  Reduction of group B streptococcal maternal and neonatal infections in preterm pregnancies with premature rupture of membranes through a rapid identification test.

Authors:  W J Morales; D Lim
Journal:  Am J Obstet Gynecol       Date:  1987-07       Impact factor: 8.661

7.  Unusual occurrence of an epidemic of type Ib/c group B streptococcal sepsis in a neonatal intensive care unit.

Authors:  F J Noya; M A Rench; T G Metzger; G Colman; J Naidoo; C J Baker
Journal:  J Infect Dis       Date:  1987-06       Impact factor: 5.226

8.  Group B streptococcal carriage and disease: a 6-year prospective study.

Authors:  H C Dillon; S Khare; B M Gray
Journal:  J Pediatr       Date:  1987-01       Impact factor: 4.406

9.  Intrapartum chemoprophylaxis of early-onset group B streptococcal disease.

Authors:  R Matorras; A García-Perea; F Omeñaca; M Diez-Enciso; R Madero; J A Usandizaga
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1991-06-05       Impact factor: 2.435

10.  Perinatal group B streptococcal colonization and infection.

Authors:  J G Allardice; T F Baskett; M M Seshia; N Bowman; R Malazdrewicz
Journal:  Am J Obstet Gynecol       Date:  1982-03-15       Impact factor: 8.661

View more
  7 in total

1.  Group B streptococcal infection risk factors.

Authors:  Keith J Barrington
Journal:  CMAJ       Date:  2002-09-17       Impact factor: 8.262

2.  New grades for recommendations from the Canadian Task Force on Preventive Health Care.

Authors: 
Journal:  CMAJ       Date:  2003-08-05       Impact factor: 8.262

3.  Debate over group B streptococcal recommendations.

Authors:  R J Morrow
Journal:  CMAJ       Date:  2002-09-03       Impact factor: 8.262

4.  Preventing group B streptococcal infections: new recommendations.

Authors:  H Dele Davies
Journal:  Can J Infect Dis       Date:  2002-07

5.  Preventing group B streptococcal infections: New recommendations.

Authors:  H Dele Davies
Journal:  Paediatr Child Health       Date:  2002-07       Impact factor: 2.253

6.  [16-week pregnant woman with positive urine culture for group B Streptococcus (GBS) or Streptococcus agalactiae].

Authors:  Fj Guerrero García; Im Rodríguez Bravo; R Vázquez Molina
Journal:  Aten Primaria       Date:  2005-05-31       Impact factor: 1.137

7.  Management of the infant at increased risk for sepsis.

Authors: 
Journal:  Paediatr Child Health       Date:  2007-12       Impact factor: 2.253

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.